<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#Cover" roleURI="http://actuatetherapeutics.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#BalanceSheets" roleURI="http://actuatetherapeutics.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#BalanceSheetsParenthetical" roleURI="http://actuatetherapeutics.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#StatementsOfOperations" roleURI="http://actuatetherapeutics.com/role/StatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#StatementsOfStockholdersEquityDeficit" roleURI="http://actuatetherapeutics.com/role/StatementsOfStockholdersEquityDeficit" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#StatementsOfStockholdersEquityDeficitParenthetical" roleURI="http://actuatetherapeutics.com/role/StatementsOfStockholdersEquityDeficitParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#StatementsOfCashFlows" roleURI="http://actuatetherapeutics.com/role/StatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#StatementsOfCashFlowsParenthetical" roleURI="http://actuatetherapeutics.com/role/StatementsOfCashFlowsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#DescriptionOfBusinessAndBasisOfPresentation" roleURI="http://actuatetherapeutics.com/role/DescriptionOfBusinessAndBasisOfPresentation" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://actuatetherapeutics.com/role/SummaryOfSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#OtherAccruedExpenses" roleURI="http://actuatetherapeutics.com/role/OtherAccruedExpenses" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#CommitmentsAndContingencies" roleURI="http://actuatetherapeutics.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#LicensesAndAgreements" roleURI="http://actuatetherapeutics.com/role/LicensesAndAgreements" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#StockholdersEquity" roleURI="http://actuatetherapeutics.com/role/StockholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#Warrants" roleURI="http://actuatetherapeutics.com/role/Warrants" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#EquityCompensationPlans" roleURI="http://actuatetherapeutics.com/role/EquityCompensationPlans" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#NetLossPerShareAttributableToCommonStockholders" roleURI="http://actuatetherapeutics.com/role/NetLossPerShareAttributableToCommonStockholders" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#SegmentReporting" roleURI="http://actuatetherapeutics.com/role/SegmentReporting" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#SubsequentEvents" roleURI="http://actuatetherapeutics.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://actuatetherapeutics.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#OtherAccruedExpensesTables" roleURI="http://actuatetherapeutics.com/role/OtherAccruedExpensesTables" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#StockholdersEquityTables" roleURI="http://actuatetherapeutics.com/role/StockholdersEquityTables" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#WarrantsTables" roleURI="http://actuatetherapeutics.com/role/WarrantsTables" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#EquityCompensationPlansTables" roleURI="http://actuatetherapeutics.com/role/EquityCompensationPlansTables" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#NetLossPerShareAttributableToCommonStockholdersTables" roleURI="http://actuatetherapeutics.com/role/NetLossPerShareAttributableToCommonStockholdersTables" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#SegmentReportingTables" roleURI="http://actuatetherapeutics.com/role/SegmentReportingTables" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" roleURI="http://actuatetherapeutics.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" roleURI="http://actuatetherapeutics.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#OtherAccruedExpensesDetails" roleURI="http://actuatetherapeutics.com/role/OtherAccruedExpensesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://actuatetherapeutics.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#LicensesAndAgreementsDetailsNarrative" roleURI="http://actuatetherapeutics.com/role/LicensesAndAgreementsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#StockholdersEquityDetails-ReservedShares" roleURI="http://actuatetherapeutics.com/role/StockholdersEquityDetails-ReservedShares" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#StockholdersEquityDetailsNarrative" roleURI="http://actuatetherapeutics.com/role/StockholdersEquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#WarrantsDetails-WarrantsOutstanding" roleURI="http://actuatetherapeutics.com/role/WarrantsDetails-WarrantsOutstanding" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#WarrantsDetailsNarrative" roleURI="http://actuatetherapeutics.com/role/WarrantsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#EquityCompensationPlansDetails-RsaUnvestedActivity" roleURI="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-RsaUnvestedActivity" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#EquityCompensationPlansDetails-RsusUnvestedActivity" roleURI="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-RsusUnvestedActivity" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#EquityCompensationPlansDetails-OptionActivity" roleURI="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-OptionActivity" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#EquityCompensationPlansDetails-Assumptions" roleURI="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-Assumptions" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#EquityCompensationPlansDetails-ShareBasedCompensation" roleURI="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-ShareBasedCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#EquityCompensationPlansDetailsNarrative" roleURI="http://actuatetherapeutics.com/role/EquityCompensationPlansDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#NetLossPerShareAttributableToCommonStockholdersDetails-Computation" roleURI="http://actuatetherapeutics.com/role/NetLossPerShareAttributableToCommonStockholdersDetails-Computation" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#NetLossPerShareAttributableToCommonStockholdersDetails-AntidilutiveShares" roleURI="http://actuatetherapeutics.com/role/NetLossPerShareAttributableToCommonStockholdersDetails-AntidilutiveShares" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#SegmentReportingDetails-ResearchAndDevelopmentExpenses" roleURI="http://actuatetherapeutics.com/role/SegmentReportingDetails-ResearchAndDevelopmentExpenses" />
    <link:roleRef xlink:type="simple" xlink:href="actu-20260630.xsd#SegmentReportingDetailsNarrative" roleURI="http://actuatetherapeutics.com/role/SegmentReportingDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="actu-20260630.xsd#ACTU_LicensePayableNoncurrent" xlink:label="loc_ACTULicensePayableNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_ACTULicensePayableNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actu-20260630.xsd#ACTU_ProceedsFromIssuanceOfCommonStock1" xlink:label="loc_ACTUProceedsFromIssuanceOfCommonStock1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ACTUProceedsFromIssuanceOfCommonStock1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/StatementsOfCashFlowsParenthetical" xlink:title="00000008 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="999014 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/OtherAccruedExpenses" xlink:title="999016 - Disclosure - OTHER ACCRUED EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/CommitmentsAndContingencies" xlink:title="999017 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/LicensesAndAgreements" xlink:title="999018 - Disclosure - LICENSES AND AGREEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/StockholdersEquity" xlink:title="999019 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/Warrants" xlink:title="999020 - Disclosure - WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/EquityCompensationPlans" xlink:title="999021 - Disclosure - EQUITY COMPENSATION PLANS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/NetLossPerShareAttributableToCommonStockholders" xlink:title="999022 - Disclosure - Net Loss Per Share Attributable to Common Stockholders" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/SegmentReporting" xlink:title="999023 - Disclosure - SEGMENT REPORTING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/SubsequentEvents" xlink:title="999024 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/OtherAccruedExpensesTables" xlink:title="999026 - Disclosure - OTHER ACCRUED EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/StockholdersEquityTables" xlink:title="999027 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/WarrantsTables" xlink:title="999028 - Disclosure - WARRANTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/EquityCompensationPlansTables" xlink:title="999029 - Disclosure - EQUITY COMPENSATION PLANS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/NetLossPerShareAttributableToCommonStockholdersTables" xlink:title="999030 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/SegmentReportingTables" xlink:title="999031 - Disclosure - SEGMENT REPORTING (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="999032 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999033 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/OtherAccruedExpensesDetails" xlink:title="999034 - Disclosure - OTHER ACCRUED EXPENSES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999035 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/LicensesAndAgreementsDetailsNarrative" xlink:title="999036 - Disclosure - LICENSES AND AGREEMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/StockholdersEquityDetails-ReservedShares" xlink:title="999037 - Disclosure - STOCKHOLDERS&apos; EQUITY (Details - Reserved shares)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/StockholdersEquityDetailsNarrative" xlink:title="999038 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/WarrantsDetails-WarrantsOutstanding" xlink:title="999039 - Disclosure - WARRANTS (Details - Warrants outstanding)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/WarrantsDetailsNarrative" xlink:title="999040 - Disclosure - WARRANTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-RsaUnvestedActivity" xlink:title="999041 - Disclosure - EQUITY COMPENSATION PLANS (Details - RSA Unvested activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-RsusUnvestedActivity" xlink:title="999042 - Disclosure - EQUITY COMPENSATION PLANS (Details - RSUs Unvested activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-OptionActivity" xlink:title="999043 - Disclosure - EQUITY COMPENSATION PLANS (Details - Option activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-Assumptions" xlink:title="999044 - Disclosure - EQUITY COMPENSATION PLANS (Details - Assumptions)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/EquityCompensationPlansDetails-ShareBasedCompensation" xlink:title="999045 - Disclosure - EQUITY COMPENSATION PLANS (Details - Share based compensation)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/EquityCompensationPlansDetailsNarrative" xlink:title="999046 - Disclosure - EQUITY COMPENSATION PLANS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/NetLossPerShareAttributableToCommonStockholdersDetails-Computation" xlink:title="999047 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details - Computation)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/NetLossPerShareAttributableToCommonStockholdersDetails-AntidilutiveShares" xlink:title="999048 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details - Antidilutive shares)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/SegmentReportingDetails-ResearchAndDevelopmentExpenses" xlink:title="999049 - Disclosure - SEGMENT REPORTING (Details - Research and development expenses)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://actuatetherapeutics.com/role/SegmentReportingDetailsNarrative" xlink:title="999050 - Disclosure - SEGMENT REPORTING (Details Narrative)" />
</link:linkbase>
